Best practices for veterinary toxicologic clinical pathology,with emphasis on the pharmaceutical and biotechnology industries

The purpose of this paper by the Regulatory Affairs Committee (RAC) of the American Society for Veterinary Clinical Pathology (ASVCP) is to review the current regulatory guidances (eg, guidelines) and published recommendations for best practices in veterinary toxicologic clinical pathology, particularly in the pharmaceutical and biotechnology industries, and to utilize the combined experience of ASVCP RAC to provide updated recommendations. Discussion points include (1) instrumentation, validation, and sample collection, (2) routine laboratory variables, (3) cytologic laboratory variables, (4) data interpretation and reporting (including peer review, reference intervals and statistics), and (5) roles and responsibilities of clinical pathologists and laboratory personnel. Revision and improvement of current practices should be in alignment with evolving regulatory guidance documents, new technology, and expanding understanding and utility of clinical pathology. These recommendations provide a contemporary guide for the refinement of veterinary toxicologic clinical pathology best practices.     

Reducing blood volume requirements for clinical pathology testing in toxicologic studies—points to consider

In preclinical safety assessment, blood volume requirements for various endpoints pose a major challenge. The goal of this working group was to review current practices for clinical pathology (CP) testing in preclinical toxicologic studies, and to discuss advantages and disadvantages of methods for reducing blood volume requirements. An industry‐wide survey was conducted to gather information on CP instrumentation and blood collection practices for hematology, clinical biochemistry, and coagulation evaluation in laboratory animals involved in preclinical studies. Based on the survey results and collective experience of the authors, the working group proposes the following “points to consider” for CP testing: (1) For most commercial analyzers, 0.5 mL and 0.8 mL of whole blood are sufficient for hematology and biochemistry evaluation, respectively. (2) Small analyzers with low volume requirements and low throughput have limited utility in preclinical studies. (3) Sample pooling or dilution is inappropriate for many CP methods. (4) Appropriate collection sites should be determined based on blood volume requirements and technical expertise. (5) Microsampling does not provide sufficient volume given current analyzer and quality assurance requirements. (6) Study design considerations include: the use of older/larger animals (rodents), collection of CP samples before toxicokinetic samples, use of separate subsets of mice for hematology and clinical biochemistry testing, use of a priority list for clinical biochemistry, and when possible, eliminating coagulation testing.     

Veterinary pathology in Europe in the light of the congresses of the European Society of Veterinary Pathology in the last decade

This paper presents the main trends in the activity of European veterinary pathologists in the context of their oral presentations (plenary lectures and short presentations) and posters provided during annual meetings of the European Society of Veterinary Pathology (ESVP), in the decade 1997-2006. It was found that the issue that was most often brought up in the meetings was organ pathology (566 presentations). Infectious and parasitical diseases were only slightly less frequent (548 presentations). Oncology was another common issue (404 presentations). During this decade, 52 plenary lectures were presented, 765 oral presentations and 1 072 posters. Altogether, 1 889 presentations were made, which is between 127 and 238 per year. Research by Polish scientists accounted for 3.16% of all presentations. Additionally, the subject matter discussed at the annual meetings is analysed, and the trends in the development of veterinary diagnostic pathology and broad pathology education are indicated. It is shown that veterinary pathology enhances knowledge in the field of veterinary medicine by fulfilling a cognitive and diagnostic role.     

蜂产业成本收益变动分析

近年来,各地蜂产业取得了较快的发展,但劳动力工价、产品价格、饲料价格等也发生了较大变化,同时,由于蜂产业受天气、地理环境、饲养管理技术、养殖方式等内外部因素的影响较大,全国不同区域蜂农之间的经济效益存在较大的差异。利用蜂产业技术体系产业经济课题组已构建的数据库,对不同地区蜂农2009-2012年的成本收益变动情况进行了整理分析,试图在详细了解蜂农成本收益结构的基础上,横向与纵向相结合分析当前蜂产业的经济效益情况。     

牛肉产业机会何在

我国的牛肉行业在全球经济一体化中国际竞争力如何,对非疯牛病疫区的我国来说,相关企业能否扩大出口牛肉及其制品,成功地把握住市场商机,有否成功的经营模式可借鉴,中国的肉牛企业机会何在?本文将对此进行详细的探讨。人均产量/(kg/人)1全球牛肉市场的变化过去20年来,全球的肉类需求增长了25%,这主要是人口和收入增长的结果,地区间人口分布差异,正在改变地区肉类的消费分布。西欧和日本成熟的消费市场显示出人口的负增长,肉类消费趋于饱和。中、低收入地区人口和收入的双增长,是肉类消费的新兴市场,将成为世界肉类消费增长的最大动力。中国…     

Establishment of the European College of Veterinary Clinical Pathology (ECVCP) and the current status of veterinary clinical pathology in Europe

After 5 years of development, the European College of Veterinary Clinical Pathology (ECVCP) was formally recognized and approved on July 4, 2007 by the European Board of Veterinary Specialisation (EBVS), the European regulatory body that oversees specialization in veterinary medicine and which has approved 23 colleges. The objectives, committees, basis for membership, constitution, bylaws, information brochure and certifying examination of the ECVCP have remained unchanged during this time except as directed by EBVS. The ECVCP declared full functionality based on the following criteria: 1) a critical mass of 65 members: 15 original diplomates approved by the EBVS to establish the ECVCP, 37 de facto diplomates, 7 diplomates certified by examination, and 5 elected honorary members; 2) the development and certification of training programs, laboratories, and qualified supervisors for residents; currently there are 18 resident training programs in Europe; 3) administration of 3 annual board-certifying examinations thus far, with an overall pass rate of 70%; 4) European consensus criteria for assessing the continuing education of specialists every 5 years; 5) organization of 8 annual scientific congresses and a joint journal (with the American Society for Veterinary Clinical Pathology) for communication of scientific research and information; the College also maintains a website, a joint listserv, and a newsletter; 6) collaboration in training and continuing education with relevant colleges in medicine and pathology; 7) development and strict adherence to a constitution and bylaws compliant with the EBVS; and 8) demonstration of compelling rationale, supporting data, and the support of members and other colleges for independence as a specialty college. Formal EBVS recognition of ECVCP as the regulatory body for the science and practice of veterinary clinical pathology in Europe will facilitate growth and development of the discipline and compliance of academic, commercial diagnostic, and industry laboratories in veterinary clinical pathology. Future needs are in developing sponsorship for resident positions, increasing employment opportunities, increasing compliance with laboratory, training, and continuing education standards, and advancing relevant science and technology.     

Veterinary pathology in the United Kingdom: past, present, and future

This article presents a historical perspective on veterinary anatomic pathology in the United Kingdom from the late nineteenth century to the present. Prior to World War II, the specialty was a rather general one that also included bacteriology and parasitology and was only slightly affected by strong Germanic developments in cell and tissue pathology. The few notable figures of this era include John McFadyean, Sidney Gaiger, and J.R.M Innes. The specialty developed strongly in the second half of the twentieth century, led by a small number of individuals, and was greatly aided by the development of specialist colleges and residency training. Key individuals of this era include W.F. Blakemore, Ernest Cotchin, R.J.M. Franklin, W.F.H. Jarrett, A.R. Jennings, and A.C. Palmer. A remarkable feature of this period has been the increased employment of veterinary pathologists in biomedical industry and in private diagnostic laboratories. While standards of pathology practice have benefited from the college initiatives, there are major financial constraints on the availability of funded training posts in the United Kingdom, and there remain considerable shortages in the supply of pathologists trained to contemporary standards. The acknowledged professional and scientific importance of veterinary pathology needs to be translated into effective financial support for the training that underpins competence in this specialty. Further developments seem likely to be dominated by advances in the technology of tissue handling, applications of molecular biology to pathology, and greater use of telepathology in teaching, in quality assurance, and in continuing professional development.